CompanyGraph
At a glance
- Depends onUpstream position: supplies 5 industries, depends on 1
- ScaleMarket cap is $3.86B, above the global median of $1.15B
- FinancialsAltman Z-Score 4.06: safe zone
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.80%
Annual Rate
EUR 0.18Paid annual
Payout Ratio
20.0%Sustainable
Last Ex-Dividend
Feb 4, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
3.34BEUR3.86B · vs all stocks (USD)
Trailing P/E
24.94xvs Medical Instruments & Supplies peers
Revenue (TTM)
1.02BEUR1.18B · vs all stocks (USD)
Profit Margin
13.40%vs Medical Instruments & Supplies peers
Beta
0.9810xvs all stocks
52-Week Change
-3.00%vs all stocks
Market Capitalization
3.34BEUR3.86B · vs all stocks (USD)
Enterprise Value
3.51BEUR4.06B · vs all stocks (USD)
Trailing P/E
24.94xvs Medical Instruments & Supplies peers
Forward P/E
20.84xvs Medical Instruments & Supplies peers
PEG Ratio
-1.30xvs Medical Instruments & Supplies peers
Price to Sales (TTM)
3.33xvs Medical Instruments & Supplies peers
Price to Book (MRQ)
3.37xvs Medical Instruments & Supplies peers
Enterprise to Revenue
3.45xvs Medical Instruments & Supplies peers
Enterprise to EBITDA
14.09xvs Medical Instruments & Supplies peers
Gross Margin
30.30%vs Medical Instruments & Supplies peers
Profit Margin
13.40%vs Medical Instruments & Supplies peers
Operating Margin
17.36%vs Medical Instruments & Supplies peers
Return on Assets (TTM)
6.49%vs Medical Instruments & Supplies peers
Return on Equity (TTM)
14.67%vs Medical Instruments & Supplies peers
Revenue (TTM)
1.02BEUR1.18B · vs all stocks (USD)
Revenue per Share (TTM)
6.73EURUpdated Aug 19, 2026Quarterly Revenue Growth
10.00%vs Medical Instruments & Supplies peers
Gross Profit (TTM)
316.90MEUR366.82M · vs all stocks (USD)
EBITDA (TTM)
287.74MEUR333.06M · vs all stocks (USD)
Net Income (TTM)
136.22MEUR157.67M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-14.50%vs Medical Instruments & Supplies peers
Operating Cash Flow (TTM)
192.92MEUR223.30M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
-19.74MEUR-22.85M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.1800EURUpdated Aug 19, 2026Trailing Annual Dividend Yield
0.80%vs all stocks
Payout Ratio
20.00%vs Medical Instruments & Supplies peers
Minority Interest (Equity)
1.97MEURFY2025 · Sep 30, 2025Revenue
986.21MEURFY2025 · Sep 30, 2025Cost of Goods Sold
653.75MEURFY2025 · Sep 30, 2025Gross Profit
332.46MEURFY2025 · Sep 30, 2025Operating Income
186.97MEUR216.42M · vs all stocks (USD)
Pre-tax Income
187.76MEURFY2025 · Sep 30, 2025Income Tax Expense
40.77MEURFY2025 · Sep 30, 2025Net Income
146.98MEURFY2025 · Sep 30, 2025EBIT
207.77MEURFY2025 · Sep 30, 2025EBITDA (Income Statement)
288.15MEURFY2025 · Sep 30, 2025Research & Development
27.92MEURFY2025 · Sep 30, 2025Selling, General & Administrative
129.88MEURFY2025 · Sep 30, 2025Other Operating Expenses
2.17MEURFY2025 · Sep 30, 2025Non-operating Interest Income
7.95MEURFY2025 · Sep 30, 2025Non-operating Interest Expense
20.01MEURFY2025 · Sep 30, 2025EPS (Basic)
0.9700EURFY2025 · Sep 30, 2025EPS (Diluted)
0.9700EURFY2025 · Sep 30, 2025Basic Shares Outstanding
150.62MSharesFY2025 · Sep 30, 2025Diluted Shares Outstanding
150.62MSharesFY2025 · Sep 30, 2025Net Income from Continuing Operations
146.98MEURFY2025 · Sep 30, 2025Minority Interests (P&L)
-528.00KEURFY2025 · Sep 30, 2025Preferred Stock Dividends
0.00EURFY2025 · Sep 30, 2025Operating Cash Flow
78.57MEURFY2025 · Sep 30, 2025Free Cash Flow
-64.11MEURFY2025 · Sep 30, 2025Cash & Cash Equivalents (End of Period)
22.47MEURFY2025 · Sep 30, 2025Starting Profit (CF Statement)
146.98MEURFY2025 · Sep 30, 2025Other Non-cash Items
-9.89MEURFY2025 · Sep 30, 2025Change in Accounts Receivable (CF)
-60.84MEURFY2025 · Sep 30, 2025Change in Other Assets/Liabilities
2.32MEURFY2025 · Sep 30, 2025Capital Expenditures
-142.68MEURFY2025 · Sep 30, 2025Net Intangibles (CF)
-434.00KEURFY2025 · Sep 30, 2025Purchase of Investments
-2.60MEURFY2025 · Sep 30, 2025Sale of Investments
2.60MEURFY2025 · Sep 30, 2025Other Investing Activity
-15.92MEURFY2025 · Sep 30, 2025Net Investing Cash Flow
-158.60MEURFY2025 · Sep 30, 2025Common Dividends Paid
-24.10MEURFY2025 · Sep 30, 2025Other Financing Charges
8.29MEURFY2025 · Sep 30, 2025Net Financing Cash Flow
-15.81MEURFY2025 · Sep 30, 2025Shares Outstanding
150.61MSharesUpdated Aug 19, 2026Float Shares
34.35MSharesUpdated Aug 19, 2026% Held by Insiders
77.00%vs all stocks
% Held by Institutions
19.29%vs all stocks
Total Cash (MRQ)
24.88MEUR28.80M · vs all stocks (USD)
Total Cash per Share (MRQ)
0.1670EURUpdated Aug 19, 2026Total Debt (MRQ)
308.26MEUR356.81M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.3088xvs Medical Instruments & Supplies peers
Current Ratio (MRQ)
1.61xvs Medical Instruments & Supplies peers
Book Value per Share (MRQ)
6.67EURUpdated Aug 19, 2026Total Assets
1.60BEUR1.85B · vs all stocks (USD)
Total Current Assets
681.40MEURFY2025 · Sep 30, 2025Total Liabilities
704.90MEURFY2025 · Sep 30, 2025Total Non-current Assets
917.25MEURFY2025 · Sep 30, 2025Total Non-current Liabilities
251.05MEURFY2025 · Sep 30, 2025Total Current Liabilities
453.85MEURFY2025 · Sep 30, 2025Cash
1.00KEURFY2025 · Sep 30, 2025Cash Equivalents
22.47MEURFY2025 · Sep 30, 2025Cash & Cash Equivalents
22.47MEURFY2025 · Sep 30, 2025Other Short-term Investments
3.20MEURFY2025 · Sep 30, 2025Accounts Receivable
201.36MEURFY2025 · Sep 30, 2025Inventory
174.97MEURFY2025 · Sep 30, 2025Accounts Payable
103.88MEURFY2025 · Sep 30, 2025Short-term Debt
3.81MEURFY2025 · Sep 30, 2025Other Current Liabilities
478.00KEURFY2025 · Sep 30, 2025Long-term Debt
79.20MEURFY2025 · Sep 30, 2025Common Stock (Book)
150.62MEURFY2025 · Sep 30, 2025Total Shareholders' Equity
893.75MEUR1.03B · vs all stocks (USD)
52-Week Low
12.62EURUpdated Aug 19, 202652-Week High
24.00EURUpdated Aug 19, 202652-Week Change
-3.00%vs all stocks
Beta
0.9810xvs all stocks
50-Day MA
19.45EURUpdated Aug 19, 2026200-Day MA
16.43EURUpdated Aug 19, 2026Avg 10-Day Volume
75.74KSharesUpdated Aug 19, 2026Avg 30-Day Volume
75.41KSharesUpdated Aug 19, 2026Diluted EPS (TTM)
0.9000EURUpdated Aug 19, 20261 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company growing?
Multi-Year Revenue, Profit, And Income Growth
Revenue has risen in each of three years, gross profit in each of four, and it has made a profit in all five.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 4.06: safe zoneNotable
Altman Z-Score: 4.06
Supply Chain
Upstream position: supplies 5 industries, depends on 1Notable
Outgoing: 5.00Incoming: 1.00
Scale
Market cap is $3.86B, above the global median of $1.15BNotable
Market cap (USD): 3,861,551,658.68Global Median: 1,146,734,693.424
Revenue is $1.18B, above the global median of $520.53MNotable
Revenue (USD): 1,176,951,778.24Global Median: 520,528,949.311
Companies that share the same coordination system — how they create, deliver, or capture value.
ERG S.p.A.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
TransAlta Corporation
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Narayana Hrudayalaya Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Jones Tech PLC
Tier 1ProductionThroughput-Bound ConversionFlowRule
Bel Fuse Inc.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Shenzhen Jove Enterprise Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Delek US Holdings Inc.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Shanghai Bright Power Semiconductor Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Tianshan Material Co. Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Hubei Zhenhua Chemical Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Companies that share active interpretations — structural patterns currently present in both stocks.
ATI Inc.
1 interpretationMulti-Year Revenue, Profit, And Income Growth
BJ's Wholesale Club Holdings, Inc.
1 interpretationMulti-Year Revenue, Profit, And Income Growth
Brown & Brown Inc.
1 interpretationMulti-Year Revenue, Profit, And Income Growth